“By attaching a chemotherapy drug to an antibody, doctors are able to deliver more potent cancer-fighting medicines directly into tumor cells, all while causing fewer side effects.

The chemotherapy-antibody combinations, known as antibody drug conjugates, have been described as both heat-seeking missiles and Trojan horses for cancer cells…

New research on two different antibody drug conjugates, presented Sunday at the American Society of Clinical Oncology conference in Chicago, found that the treatments helped patients with multiple myeloma and breast cancer live longer without their cancers progressing further.”

From NBC News.